Phrontline Biopharma Starts Phase I/II Trials for Dual-Payload ADC TJ102 #China #Hangzhou #Phrontline_Biopharma #bispecific_ADC #TJ102
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialAkeso's Breakthrough Bispecific ADC Receives NMPA Phase I Clearance for Solid Tumors #China #Hong_Kong #Akeso #bispecific_ADC #AK158D1